HISA has formed an alliance with the Texas Medical Centre on a new international BioBridge, a health technology startup exchange program.
It will enable selected Australian digital health companies or individual health entrepreneurs to spend four months in immersion programs in Houston.
Through the program, Australian companies will be provided critical services at no cost, including: legal, business planning, regulatory counsel and access to the eight million patient encounters at the TMC annually.
The initiative is supported by Austrade
Applications are invited now for the TMCx upcoming Digital Health cohort, beginning February 13, 2017.
The application deadline is December 23, 2016.
For more information, apply online HERE.
Recruitment for the Medical Device cohort will begin in June 2017.
Message from HISA CEO Dr Louise Schaper
“This provides ground-breaking opportunities for those working in innovative technology and product development in the health and medical sector in Australia.
TMC is world renowned for its innovation in medical research and this alliance brings an immediate and real opportunity for Australia’s best and brightest to learn from some of the world’s top health innovators on a scale we don’t yet see in Australia.”
We believe TMC offers a unique learning experience for Australians to test and learn how to embed their innovation within an active, large medical centre – it’s a rare opportunity to have real users involved in the co-design and co-creation process. Importantly, over the longer term, the alliance provides the foundations for growing a bi-lateral innovation and technology transfer between Australia and the USA in digital health and medical technology.”